| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.33 | 4e-18 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.41 | 1e-16 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-12 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-11 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-10 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.21 | 6e-10 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-09 |